Gerken M - Search Results

1

Expression and function of beta-glucuronidase in pancreatic cancer: potential role in drug targeting.

Sperker B, Werner U, Mürdter TE, Tekkaya C, Fritz P, Wacke R, Adam U, Gerken M, Drewelow B, Kroemer HK. Sperker B, et al. Among authors: gerken m. Naunyn Schmiedebergs Arch Pharmacol. 2000 Aug;362(2):110-5. doi: 10.1007/s002100000260. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 10961372

2

Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase.

Mürdter TE, Friedel G, Backman JT, McClellan M, Schick M, Gerken M, Bosslet K, Fritz P, Toomes H, Kroemer HK, Sperker B. Mürdter TE, et al. Among authors: gerken m. J Pharmacol Exp Ther. 2002 Apr;301(1):223-8. doi: 10.1124/jpet.301.1.223. J Pharmacol Exp Ther. 2002. PMID: 11907177

3

Elucidation of the mechanism enabling tumor selective prodrug monotherapy.

Bosslet K, Straub R, Blumrich M, Czech J, Gerken M, Sperker B, Kroemer HK, Gesson JP, Koch M, Monneret C. Bosslet K, et al. Among authors: gerken m. Cancer Res. 1998 Mar 15;58(6):1195-201. Cancer Res. 1998. PMID: 9515805

4

Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.

Florent JC, Dong X, Gaudel G, Mitaku S, Monneret C, Gesson JP, Jacquesy JC, Mondon M, Renoux B, Andrianomenjanahary S, Michel S, Koch M, Tillequin F, Gerken M, Czech J, Straub R, Bosslet K. Florent JC, et al. Among authors: gerken m. J Med Chem. 1998 Sep 10;41(19):3572-81. doi: 10.1021/jm970589l. J Med Chem. 1998. PMID: 9733483

5

Application of the ADEPT strategy to the MDR resistance in cancer chemotherapy.

Desbene S, Van HD, Michel S, Tillequin F, Koch M, Schmidt F, Florent JC, Monneret C, Straub R, Czech J, Gerken M, Bosslet K. Desbene S, et al. Among authors: gerken m. Anticancer Drug Des. 1999 Apr;14(2):93-106. Anticancer Drug Des. 1999. PMID: 10405636

6

Synthesis and cytotoxic activity of a glucuronylated prodrug of nornitrogen mustard.

Papot S, Combaud D, Bosslet K, Gerken M, Czech J, Gesson JP. Papot S, et al. Among authors: gerken m. Bioorg Med Chem Lett. 2000 Aug 21;10(16):1835-7. doi: 10.1016/s0960-894x(00)00353-x. Bioorg Med Chem Lett. 2000. PMID: 10969980

7

Human erythropoietin-specific sites of monoclonal antibody-mediated neutralization.

Fibi MR, Aslan M, Hintz-Obertreis P, Pauly JU, Gerken M, Lüben G, Lauffer L, Siebold B, Stüber W, Nau G, et al. Fibi MR, et al. Among authors: gerken m. Blood. 1993 Feb 1;81(3):670-5. Blood. 1993. PMID: 7678997 Free article.

8

Fluoride-Ion Donor Properties of AsF₅.

O'Donnell F, Wetmore SD, Gerken M. O'Donnell F, et al. Among authors: gerken m. Inorg Chem. 2024 Apr 17. doi: 10.1021/acs.inorgchem.3c04143. Online ahead of print. Inorg Chem. 2024. PMID: 38629175

9

Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 years.

Baecher H, Gerken M, Knoedler L, Knoedler S, Alfertshofer M, Klinkhammer-Schalke M, Berneburg M, Drexler K, Haferkamp S. Baecher H, et al. Among authors: gerken m. J Plast Reconstr Aesthet Surg. 2024 Mar 1;92:33-47. doi: 10.1016/j.bjps.2024.02.056. Online ahead of print. J Plast Reconstr Aesthet Surg. 2024. PMID: 38489985 Free article.

10

The role of human capital and stress for cost awareness in the healthcare system: a survey among German hospital physicians.

Lüdemann C, Gerken M, Hülsbeck M. Lüdemann C, et al. Among authors: gerken m. BMC Health Serv Res. 2024 Mar 7;24(1):310. doi: 10.1186/s12913-024-10748-z. BMC Health Serv Res. 2024. PMID: 38454403 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page